Matches in SemOpenAlex for { <https://semopenalex.org/work/W2175508742> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2175508742 endingPage "9" @default.
- W2175508742 startingPage "1185" @default.
- W2175508742 abstract "The standard chemotherapy for the treatment of unresectable advanced and recurrent biliary tract cancers is considered gemcitabine plus cisplatin (GC) on the basis of favorable results reported in the ABC-02 study from the UK and the BT22 study from Japan. However, the GC cohort of the BT22 study consisted of only 42 patients, and we considered it necessary to confirm the effectiveness and safety of GC chemotherapy in a multicenter prospective observational study in Fukuoka. Thirty-seven patients were enrolled in this study, including two patients with recurrent disease. The median patient age was 67.5 years (range, 43-84 years). Twelve patients had intrahepatic cholangiocarcinoma, 13 patients had extrahepatic cholangiocarcinoma, and 12 patients had gallbladder cancer. The median survival time (MST) was 14.9 months, the 1-year survival rate was 54.5%, and the median progression free survival (PFS) was 7.7 months. No chemotherapy-related deaths occurred, and Grade 3/4 adverse events were mainly hematological events including leucopenia in 13 (35.1%) patients and neutropenia in 12 (32.4%). The MST, 1-year survival rate, median PFS, and rate of Grade 3/4 adverse events in our study were similar to those of the BT22 study. In conclusion, this multicenter prospective observational study confirms the effectiveness and safety of GC chemotherapy for the treatment of unresectable advanced and recurrent biliary tract cancers." @default.
- W2175508742 created "2016-06-24" @default.
- W2175508742 creator A5014811179 @default.
- W2175508742 creator A5020572688 @default.
- W2175508742 creator A5024065137 @default.
- W2175508742 creator A5031055958 @default.
- W2175508742 creator A5047088276 @default.
- W2175508742 creator A5052639201 @default.
- W2175508742 creator A5053641192 @default.
- W2175508742 creator A5054687903 @default.
- W2175508742 creator A5069965644 @default.
- W2175508742 creator A5070866316 @default.
- W2175508742 creator A5081888711 @default.
- W2175508742 creator A5085405229 @default.
- W2175508742 creator A5088590521 @default.
- W2175508742 date "2015-10-01" @default.
- W2175508742 modified "2023-10-16" @default.
- W2175508742 title "[Gemcitabine in Combination with Cisplatin in Patients with Unresectable Advanced or Recurrent Biliary Tract Cancer--A Multicenter Prospective Observational Study in Fukuoka]." @default.
- W2175508742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26489546" @default.
- W2175508742 hasPublicationYear "2015" @default.
- W2175508742 type Work @default.
- W2175508742 sameAs 2175508742 @default.
- W2175508742 citedByCount "1" @default.
- W2175508742 countsByYear W21755087422020 @default.
- W2175508742 crossrefType "journal-article" @default.
- W2175508742 hasAuthorship W2175508742A5014811179 @default.
- W2175508742 hasAuthorship W2175508742A5020572688 @default.
- W2175508742 hasAuthorship W2175508742A5024065137 @default.
- W2175508742 hasAuthorship W2175508742A5031055958 @default.
- W2175508742 hasAuthorship W2175508742A5047088276 @default.
- W2175508742 hasAuthorship W2175508742A5052639201 @default.
- W2175508742 hasAuthorship W2175508742A5053641192 @default.
- W2175508742 hasAuthorship W2175508742A5054687903 @default.
- W2175508742 hasAuthorship W2175508742A5069965644 @default.
- W2175508742 hasAuthorship W2175508742A5070866316 @default.
- W2175508742 hasAuthorship W2175508742A5081888711 @default.
- W2175508742 hasAuthorship W2175508742A5085405229 @default.
- W2175508742 hasAuthorship W2175508742A5088590521 @default.
- W2175508742 hasConcept C121608353 @default.
- W2175508742 hasConcept C126322002 @default.
- W2175508742 hasConcept C141071460 @default.
- W2175508742 hasConcept C143998085 @default.
- W2175508742 hasConcept C188816634 @default.
- W2175508742 hasConcept C197934379 @default.
- W2175508742 hasConcept C2775982439 @default.
- W2175508742 hasConcept C2776534502 @default.
- W2175508742 hasConcept C2776694085 @default.
- W2175508742 hasConcept C2777063308 @default.
- W2175508742 hasConcept C2777148285 @default.
- W2175508742 hasConcept C2780258809 @default.
- W2175508742 hasConcept C71924100 @default.
- W2175508742 hasConcept C90924648 @default.
- W2175508742 hasConceptScore W2175508742C121608353 @default.
- W2175508742 hasConceptScore W2175508742C126322002 @default.
- W2175508742 hasConceptScore W2175508742C141071460 @default.
- W2175508742 hasConceptScore W2175508742C143998085 @default.
- W2175508742 hasConceptScore W2175508742C188816634 @default.
- W2175508742 hasConceptScore W2175508742C197934379 @default.
- W2175508742 hasConceptScore W2175508742C2775982439 @default.
- W2175508742 hasConceptScore W2175508742C2776534502 @default.
- W2175508742 hasConceptScore W2175508742C2776694085 @default.
- W2175508742 hasConceptScore W2175508742C2777063308 @default.
- W2175508742 hasConceptScore W2175508742C2777148285 @default.
- W2175508742 hasConceptScore W2175508742C2780258809 @default.
- W2175508742 hasConceptScore W2175508742C71924100 @default.
- W2175508742 hasConceptScore W2175508742C90924648 @default.
- W2175508742 hasIssue "10" @default.
- W2175508742 hasLocation W21755087421 @default.
- W2175508742 hasOpenAccess W2175508742 @default.
- W2175508742 hasPrimaryLocation W21755087421 @default.
- W2175508742 hasRelatedWork W1973241390 @default.
- W2175508742 hasRelatedWork W1996138775 @default.
- W2175508742 hasRelatedWork W2027480170 @default.
- W2175508742 hasRelatedWork W2035772974 @default.
- W2175508742 hasRelatedWork W2079479533 @default.
- W2175508742 hasRelatedWork W2103529483 @default.
- W2175508742 hasRelatedWork W2468089361 @default.
- W2175508742 hasRelatedWork W2590297353 @default.
- W2175508742 hasRelatedWork W3031603506 @default.
- W2175508742 hasRelatedWork W3142786019 @default.
- W2175508742 hasVolume "42" @default.
- W2175508742 isParatext "false" @default.
- W2175508742 isRetracted "false" @default.
- W2175508742 magId "2175508742" @default.
- W2175508742 workType "article" @default.